| Kennetha L Simien, NP | |
|
475 High Hope Rd, Sulphur, LA 70663-0037 | |
| (337) 527-8140 | |
| Not Available |
| Full Name | Kennetha L Simien |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 475 High Hope Rd, Sulphur, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013550433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 208939 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Calcasieu Cameron Hospital | Sulphur, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Curana Health Of Louisiana Llc | 4880731355 | 80 |
News Archive
The spread of SARS-CoV-2 is driven by the high proportion of asymptomatic and very mild infections, allowing people to move around and engage in public activity normally. There are many modeling studies that suggest that large-scale screening for the presence of this virus can help curb transmission at this point, from people with few or no symptoms. A new study points out the accuracy of SARS-CoV-2 antigen-detection rapid diagnostic tests for this purpose when used at the point-of-care.
Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.
The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.
While every year about 30,000 men die of prostate cancer in the United States, the most common cause of death in men with prostate cancer is heart disease. That's because not all prostate cancers are the same. Some are slow-growing while others are very aggressive.
› Verified 3 days ago
| Entity Name | Curana Health Of Louisiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538399704 PECOS PAC ID: 4880731355 Enrollment ID: O20091103000048 |
News Archive
The spread of SARS-CoV-2 is driven by the high proportion of asymptomatic and very mild infections, allowing people to move around and engage in public activity normally. There are many modeling studies that suggest that large-scale screening for the presence of this virus can help curb transmission at this point, from people with few or no symptoms. A new study points out the accuracy of SARS-CoV-2 antigen-detection rapid diagnostic tests for this purpose when used at the point-of-care.
Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.
The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.
While every year about 30,000 men die of prostate cancer in the United States, the most common cause of death in men with prostate cancer is heart disease. That's because not all prostate cancers are the same. Some are slow-growing while others are very aggressive.
› Verified 3 days ago
| Entity Name | Ch Mssp Services La Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982285060 PECOS PAC ID: 6901206416 Enrollment ID: O20210621000338 |
News Archive
The spread of SARS-CoV-2 is driven by the high proportion of asymptomatic and very mild infections, allowing people to move around and engage in public activity normally. There are many modeling studies that suggest that large-scale screening for the presence of this virus can help curb transmission at this point, from people with few or no symptoms. A new study points out the accuracy of SARS-CoV-2 antigen-detection rapid diagnostic tests for this purpose when used at the point-of-care.
Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.
The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.
While every year about 30,000 men die of prostate cancer in the United States, the most common cause of death in men with prostate cancer is heart disease. That's because not all prostate cancers are the same. Some are slow-growing while others are very aggressive.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kennetha L Simien, NP 1509 Dulles Dr, Lafayette, LA 70506-3718 Ph: (337) 991-9276 | Kennetha L Simien, NP 475 High Hope Rd, Sulphur, LA 70663-0037 Ph: (337) 527-8140 |
News Archive
The spread of SARS-CoV-2 is driven by the high proportion of asymptomatic and very mild infections, allowing people to move around and engage in public activity normally. There are many modeling studies that suggest that large-scale screening for the presence of this virus can help curb transmission at this point, from people with few or no symptoms. A new study points out the accuracy of SARS-CoV-2 antigen-detection rapid diagnostic tests for this purpose when used at the point-of-care.
Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.
The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.
While every year about 30,000 men die of prostate cancer in the United States, the most common cause of death in men with prostate cancer is heart disease. That's because not all prostate cancers are the same. Some are slow-growing while others are very aggressive.
› Verified 3 days ago
Mrs. Marilyn Hopson Watson, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1200 Stelly Ln, Sulphur, LA 70663 Phone: 337-312-1000 Fax: 337-527-8963 | |
Laken Desonier Kelly, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3649 S Beglis Pkwy, 3645 S. Beglis Pkwy, Sulphur, LA 70665 Phone: 337-476-3149 | |
Amanda Kate Dawson, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 Cypress St, Sulphur, LA 70663 Phone: 337-527-6371 | |
Carly Hillebrandt, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3649 S Beglis Pkwy, Sulphur, LA 70665 Phone: 337-626-1011 Fax: 337-558-5585 | |
Angie Ewalt Dukes, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 921 1st Ave, Sulphur, LA 70663 Phone: 337-527-6385 Fax: 337-527-3527 | |
Dean Joseph Chesson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 133 Summerwood Dr, Sulphur, LA 70663 Phone: 337-304-7656 |